cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.30120711
title: When the caregiver is affected: eating disorder symptoms among mental health professionals

description: To study the lifetime and point prevalence of eating disorders (ED) among mental health care providers and compare those working with patients with ED to those who work in other fields of psychiatry to examine whether the overrepresentation of ED among professionals seen in ED clinics are also true for professionals in other psychiatric outpatient clinics. Digital questionnaires were sent out to professionals working with patients in psychiatric outpatient clinics in Sweden. The questionnaire included questions from the Mini International Neuropsychiatric Interview 7.0.1 and the Eating Disorder Examination Questionnaire 6.0. 173 respondents completed the questionnaire. The lifetime prevalence of ED among professionals in ED-clinics was 35.2% (women 41.9%, men 10.0%) and in non-ED clinics 24.4% (women 27.7%, men 16.1%). The point prevalence was 11.1 and 10.9% respectively. The lifetime prevalence of any ED in the Swedish general population is 2–3.5%. Our results suggest a 10-fold higher prevalence among mental health care providers, regardless of if working with patients with ED or not. This result could have multiple explanations; such as an increased willingness to help others based on personal experience of ED or increased risk of developing ED when working with patients with ED. There is always a risk of reporting bias when conducting studies using digital questionnaires. The findings can have implications for the psychosocial work environment and health of employees as well as for the assessment and treatment of patients. The lifetime prevalence of eating disorders (ED) was 35% among mental health care providers working with ED and 24% among mental health care providers working within other fields of psychiatry.The point prevalence of ED among the mental health care workers was 11%, regardless of if working with ED or in other fields of psychiatry.Only a few of those with a personal history of ED were open about it in their workplace, which might be due to a (self-) stigma surrounding their own problems with mental health among mental health care professionals. The lifetime prevalence of eating disorders (ED) was 35% among mental health care providers working with ED and 24% among mental health care providers working within other fields of psychiatry. The point prevalence of ED among the mental health care workers was 11%, regardless of if working with ED or in other fields of psychiatry. Only a few of those with a personal history of ED were open about it in their workplace, which might be due to a (self-) stigma surrounding their own problems with mental health among mental health care professionals.
DOI: 10.6084/m9.figshare.30120711.v1
title: When the caregiver is affected: eating disorder symptoms among mental health professionals

description: To study the lifetime and point prevalence of eating disorders (ED) among mental health care providers and compare those working with patients with ED to those who work in other fields of psychiatry to examine whether the overrepresentation of ED among professionals seen in ED clinics are also true for professionals in other psychiatric outpatient clinics. Digital questionnaires were sent out to professionals working with patients in psychiatric outpatient clinics in Sweden. The questionnaire included questions from the Mini International Neuropsychiatric Interview 7.0.1 and the Eating Disorder Examination Questionnaire 6.0. 173 respondents completed the questionnaire. The lifetime prevalence of ED among professionals in ED-clinics was 35.2% (women 41.9%, men 10.0%) and in non-ED clinics 24.4% (women 27.7%, men 16.1%). The point prevalence was 11.1 and 10.9% respectively. The lifetime prevalence of any ED in the Swedish general population is 2–3.5%. Our results suggest a 10-fold higher prevalence among mental health care providers, regardless of if working with patients with ED or not. This result could have multiple explanations; such as an increased willingness to help others based on personal experience of ED or increased risk of developing ED when working with patients with ED. There is always a risk of reporting bias when conducting studies using digital questionnaires. The findings can have implications for the psychosocial work environment and health of employees as well as for the assessment and treatment of patients. The lifetime prevalence of eating disorders (ED) was 35% among mental health care providers working with ED and 24% among mental health care providers working within other fields of psychiatry.The point prevalence of ED among the mental health care workers was 11%, regardless of if working with ED or in other fields of psychiatry.Only a few of those with a personal history of ED were open about it in their workplace, which might be due to a (self-) stigma surrounding their own problems with mental health among mental health care professionals. The lifetime prevalence of eating disorders (ED) was 35% among mental health care providers working with ED and 24% among mental health care providers working within other fields of psychiatry. The point prevalence of ED among the mental health care workers was 11%, regardless of if working with ED or in other fields of psychiatry. Only a few of those with a personal history of ED were open about it in their workplace, which might be due to a (self-) stigma surrounding their own problems with mental health among mental health care professionals.
DOI: 10.5517/ccdc.csd.cc2pwv9r
title: CCDC 2499415: Experimental Crystal Structure Determination

description: Related Article: O.I. Adaeva, D.V. Demchuk, V.V. Semenov, A.I. Samigullina, M.E. Minyaev|2025|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2pwvbs
title: CCDC 2499416: Experimental Crystal Structure Determination

description: Related Article: O.I. Adaeva, D.V. Demchuk, V.V. Semenov, A.I. Samigullina, M.E. Minyaev|2025|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.15468/dl.vyz39x
title: Occurrence Download

description: A dataset containing 2162 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "TaxonKey is Eucommia ulmoides"
 ]
}

 The dataset includes 2162 records from 92 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012294-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.21227/dac9-km18
title: "inter-turn short-circuit faults"

description: "Inter-turn short-circuit faults in permanent magnet motors"
DOI: 10.15468/dl.u2t8rh
title: Occurrence Download

description: A dataset containing 35625 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Rhizophora mangle"
 ]
}

 The dataset includes 35625 records from 406 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012295-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.34810/data2720
title: Replication Data for: A 3D Bioengineered Human Liver for the Study of Acute and Chronic Drug-Induced Hepatotoxicity and Fibrosis

description: A Bioengineered 3D Human Liver Model for Investigating Acute and Chronic Drug-Induced Hepatotoxicity and Fibrosis
Description of the Work
This dataset includes all raw and processed data generated during the development, validation, and experimental analysis of a 3D bioengineered human liver model designed to study acute and chronic drug-induced hepatotoxicity and fibrosis. The platform consists of co-cultured human hepatocytes (HepaRG), hepatic stellate cells (LX-2), and immune cells (THP-1 monocytes) encapsulated within a gelatin methacryloyl (GelMA) and carboxymethyl cellulose methacrylate (CMCMA) hydrogel matrix. The dataset encompasses transcriptomic profiles (RNA-seq), quantitative PCR gene expression, cell viability assays, metabolic enzyme activities, immunofluorescence images, fibrosis marker quantification, and inflammatory signaling data following pharmacological challenges with lipopolysaccharide (LPS), paracetamol, and dexamethasone.
Datasets are provided for time-course experiments representing both acute and chronic liver injury and for the evaluation of anti-inflammatory drug response. The repository also includes methodological metadata for all reagents, cell lines, antibodies, and experimental protocols in accordance with CTAT (Complete, Transparent, Accurate, Timely) standards. These resources enable full reproducibility and allow other investigators to replicate, validate, and extend the findings reported in the associated publication.
Data Types Provided
Raw and processed RNA-seq files (FASTQ, counts, and normalized expression tables)
qPCR results (gene expression tables and raw Ct values)
Cell viability and metabolic activity data from MTS and Live/Dead assays
Imaging data (fluorescent and confocal microscopy files)
Protein biomarker ELISA results (PINP, PIIINP, ammonia)
CYP3A4 activity assays
Cytokine quantification (Luminex multiplex assay)
Protocol documents for hydrogel fabrication, cell culture, drug treatment, sample processing, and data analysis
Potential Uses
Benchmarking and comparison of liver-on-chip models
Toxicology and drug safety studies
Fibrosis, inflammation, and liver disease mechanism research
Bioinformatics pathway analysis and computational modeling
Methods validation and protocol optimization
Associated Publication
This dataset supports the findings of:
Ferret-Miñana, A., Alcaraz, E., Horrillo, R., Ramón-Azcón, J., De Chiara, F., et al. “A 3D Bioengineered Human Liver for the Study of Acute and Chronic Drug-Induced Hepatotoxicity and Fibrosis,” JHEP Reports, 2025.
DOI: 10.5281/zenodo.17510414
title: Student Performance in Secondary Education (Portugal)

description: This dataset contains information about secondary school students in Portugal. It includes demographic, social, and academic details such as gender, age, study time, absences, and grades (G1–G3). The data was taken from a public Kaggle dataset and cleaned before upload. It can be used for educational data analysis and predicting student performance.
DOI: 10.5281/zenodo.17510413
title: Student Performance in Secondary Education (Portugal)

description: This dataset contains information about secondary school students in Portugal. It includes demographic, social, and academic details such as gender, age, study time, absences, and grades (G1–G3). The data was taken from a public Kaggle dataset and cleaned before upload. It can be used for educational data analysis and predicting student performance.
DOI: 10.34740/kaggle/dsv/13594477
title: Arabic Lega Case Dataset
DOI: 10.5281/zenodo.17510439
title: Safeguarding Nature Through Legislation - An Analysis of Pakistan's Environmental Protection Mechanisms
DOI: 10.5281/zenodo.17510440
title: Safeguarding Nature Through Legislation - An Analysis of Pakistan's Environmental Protection Mechanisms
DOI: 10.6084/m9.figshare.30514874
title: 数据共享

description: 的兔子健康显着影响生长发育，取决于三个关键因素：强大的免疫系统、适当的肠道功能和平衡的肠道微生物群。茯苓多糖 （PCP） 是茯苓的主要生物活性成分，具有多种药理特性，已被证明对动物健康有益。在这项研究中，320 只 Hyla 兔被随机分配到四个饮食组：一个接受基础饮食的对照组和三个补充 0.1%、0.2% 或 0.3% PCP 的实验组。结果表明，补充PCP可显著提高Hyla兔的生长性能和免疫器官指数。与对照组相比，PCP能够显著提高血清总蛋白、白蛋白、葡萄糖、总抗氧化能力、过氧化氢酶、谷胱甘肽过氧化物酶、免疫球蛋白A、免疫球蛋白G、免疫球蛋白M和白细胞介素-10水平，并下调血清总胆固醇、甘油三酯、丙二醛（p &lt; 0.01）、白细胞介素-6（p &lt; 0.05）、二胺氧化酶、D-乳酸和内毒素水平。
DOI: 10.6084/m9.figshare.30514874.v1
title: 数据共享

description: 的兔子健康显着影响生长发育，取决于三个关键因素：强大的免疫系统、适当的肠道功能和平衡的肠道微生物群。茯苓多糖 （PCP） 是茯苓的主要生物活性成分，具有多种药理特性，已被证明对动物健康有益。在这项研究中，320 只 Hyla 兔被随机分配到四个饮食组：一个接受基础饮食的对照组和三个补充 0.1%、0.2% 或 0.3% PCP 的实验组。结果表明，补充PCP可显著提高Hyla兔的生长性能和免疫器官指数。与对照组相比，PCP能够显著提高血清总蛋白、白蛋白、葡萄糖、总抗氧化能力、过氧化氢酶、谷胱甘肽过氧化物酶、免疫球蛋白A、免疫球蛋白G、免疫球蛋白M和白细胞介素-10水平，并下调血清总胆固醇、甘油三酯、丙二醛（p &lt; 0.01）、白细胞介素-6（p &lt; 0.05）、二胺氧化酶、D-乳酸和内毒素水平。
DOI: 10.15468/dl.qgub3h
title: Occurrence Download

description: A dataset containing 231 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Indonesia",
 "HasCoordinate is false",
 "IucnRedListCategory is VU",
 "OccurrenceStatus is Present",
 "TaxonKey is Trachypithecus auratus"
 ]
}

 The dataset includes 231 records from 8 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012298-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.mmh7d8
title: Occurrence Download

description: A dataset containing 54077 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Thailand",
 "Year is 2022",
 "InstitutionCode is iNaturalist"
 ]
}

 The dataset includes 54077 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012290-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.30514868
title: Kanki Diabetes manuscript, Supplementary Methods September 2025

description: Supplementary Methods for manuscript titled: Balcinrenone shows a unique regulation of potassium excretion in streptozotocin-induced diabetes in male mice.
DOI: 10.6084/m9.figshare.30514868.v1
title: Kanki Diabetes manuscript, Supplementary Methods September 2025

description: Supplementary Methods for manuscript titled: Balcinrenone shows a unique regulation of potassium excretion in streptozotocin-induced diabetes in male mice.
DOI: 10.15468/dl.syqxct
title: Occurrence Download

description: A dataset containing 10730 species occurrences available in GBIF matching the query:
{
 "and" : [
 "OccurrenceStatus is Present",
 "TaxonKey is Vaccinium uliginosum",
 "Year 1910-1955"
 ]
}

 The dataset includes 10730 records from 252 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012299-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.17461832
title: Additional data for "The Duality of Insect Macroevolution: Pulsed Genomes and Gradual Morphology Shape Lineage Diversification"

description: This dataset contains the phylogenetic trees (timetrees) underpinning the genomic trait evolution analyses presented in the associated study, "The Duality of Insect Macroevolution: Pulsed Genomes and Gradual Morphology Shape Lineage Diversification"". The trees represent 15 insect families and were used to investigate the dynamics of genomic evolution against patterns of morphological change and species richness. These data are provided to ensure reproducibility and to facilitate future meta-analyses in insect macroevolution.
DOI: 10.5281/zenodo.17462384
title: Additional data for "The Duality of Insect Macroevolution: Pulsed Genomes and Gradual Morphology Shape Lineage Diversification"

description: This dataset contains the phylogenetic trees (timetrees) underpinning the genomic trait evolution analyses presented in the associated study, "The Duality of Insect Macroevolution: Pulsed Genomes and Gradual Morphology Shape Lineage Diversification"". The trees represent 15 insect families and were used to investigate the dynamics of genomic evolution against patterns of morphological change and species richness. These data are provided to ensure reproducibility and to facilitate future meta-analyses in insect macroevolution.
DOI: 10.15468/dl.nzwqu2
title: Occurrence Download

description: A dataset listing the 3 species recorded in GBIF matching the query:
{
 "DatasetKey" : [
 "is Catalogue of Life"
 ]
}

 The dataset's 3 records were derived from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012297-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.v2ppts
title: Occurrence Download

description: A dataset containing 811189 species occurrences available in GBIF matching the query:
{
 "and" : [
 "PublishingOrg is 53f347a7-99ce-4528-a085-5c76eb1301a0",
 "TaxonKey is Animalia"
 ]
}

 The dataset includes 811189 records from 22 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012296-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.av77d8
title: Occurrence Download

description: A dataset containing 276 species occurrences available in GBIF matching the query:
{
 "and" : [
 "OccurrenceStatus is Present",
 "TaxonKey is Euphydryas editha",
 "Year 1910-1955"
 ]
}

 The dataset includes 276 records from 20 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012301-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.17510307
title: Early CKD Prospective Follow up Study

description: ABSTRACT

In early-stage CKD (stages 1–3) study aimed to investigate the prognostic utility of suPAR and IgM-uria compared to current standard biomarkers (eGFR and urine albumin-to-creatinine ratio (ACR)).

This prospective cohort study included a consecutive sample of patients with CKD stages 1–3 who were recruited from a medical specialty outpatient clinic between July 1, 2012, and June 16, 2016. Participants were followed until December 2023 to assess the primary outcomes. Major adverse cardiovascular outcomes (MACEs) included a composite of myocardial infarction (MI), unstable angina (UA), stroke, transient ischemic attack (TIA), or death due to cardiovascular disease (CVD). Kidney failure outcomes were defined as progression to ESKD, CKD stage 5, or a sustained decline in eGFR ≥40%.
DOI: 10.5281/zenodo.17510308
title: Early CKD Prospective Follow up Study

description: ABSTRACT

In early-stage CKD (stages 1–3) study aimed to investigate the prognostic utility of suPAR and IgM-uria compared to current standard biomarkers (eGFR and urine albumin-to-creatinine ratio (ACR)).

This prospective cohort study included a consecutive sample of patients with CKD stages 1–3 who were recruited from a medical specialty outpatient clinic between July 1, 2012, and June 16, 2016. Participants were followed until December 2023 to assess the primary outcomes. Major adverse cardiovascular outcomes (MACEs) included a composite of myocardial infarction (MI), unstable angina (UA), stroke, transient ischemic attack (TIA), or death due to cardiovascular disease (CVD). Kidney failure outcomes were defined as progression to ESKD, CKD stage 5, or a sustained decline in eGFR ≥40%.
DOI: 10.5281/zenodo.17406100
title: Python-based LCSA Framework

description: This repository contains a comprehensive Python implementation of a Life Cycle Sustainability Assessment (LCSA) framework tailored for transportation systems. It integrates multi-criteria assessment encompassing environmental, economic, and social dimensions, enhanced by machine learning models including multi-target Random Forest regressors for accurate prediction of key impact indicators. The code supports scenario analysis, uncertainty quantification via Monte Carlo simulations, and generates detailed visualizations and rankings to guide sustainable transport decision-making. This framework enables analysts and policymakers to evaluate trade-offs and identify sustainable routing and operational strategies, contributing robust, data-driven insights for decarbonization, cost efficiency, and social risk reduction in freight logistics.
DOI: 10.5281/zenodo.17406099
title: Python-based LCSA Framework

description: This repository contains a comprehensive Python implementation of a Life Cycle Sustainability Assessment (LCSA) framework tailored for transportation systems. It integrates multi-criteria assessment encompassing environmental, economic, and social dimensions, enhanced by machine learning models including multi-target Random Forest regressors for accurate prediction of key impact indicators. The code supports scenario analysis, uncertainty quantification via Monte Carlo simulations, and generates detailed visualizations and rankings to guide sustainable transport decision-making. This framework enables analysts and policymakers to evaluate trade-offs and identify sustainable routing and operational strategies, contributing robust, data-driven insights for decarbonization, cost efficiency, and social risk reduction in freight logistics.
DOI: 10.34740/kaggle/dsv/13594579
title: Peer-to-Peer Boliviano (BOB) Exchange Data
DOI: 10.6084/m9.figshare.30514931
title: Supplementary Material for: To What Extent Do Clinical Practice Guidelines for Chronic Diseases Embrace Current Obesity Management Guidance? A Qualitative Content Analysis

description: Introduction: Obesity is a chronic, progressive, and recurring disease that contributes significantly to multimorbidity across Europe. Despite the publication of numerous clinical practice guidelines (CPGs) for obesity, many chronic disease guidelines for obesity related diseases such as diabetes, MASLD, heart disease, obstructive sleep apnea do not integrate contemporary understandings of obesity as an adiposity-based disease requiring direct management in its own right. The objective of this qualitative content analysis was to evaluate the extent to which recent chronic disease CPGs align with current evidence-based obesity guidance. 

Methods: A working group convened by the European Association for the Study of Obesity reviewed 13 chronic disease CPGs published since 2019. Guidelines were assessed using nine predefined criteria based on leading obesity CPGs. Data were extracted and content analysis was used to identify gaps and opportunities across the chronic disease CPGs.

Results: Three key themes were identified: (1) inconsistent scientific/medical conceptualization of obesity, (2) limited integration of evidence-based obesity management guidance, and (3) minimal inclusion of person-centred care principles. Most guidelines treated obesity as a risk factor, not a disease, and lacked reference to contemporary obesity frameworks or person-first language.

Conclusion: Greater alignment across CPGs is essential to improve obesity care within multimorbidity management. Collaborative, cross-specialty approaches are recommended to harmonize clinical guidance and promote integrated, stigma-free care.